Arai Masayoshi, Kawachi Takashi, Kotoku Naoyuki, Nakata Chiaki, Kamada Haruhiko, Tsunoda Shin-ichi, Tsutsumi Yasuo, Endo Hiroko, Inoue Masahiro, Sato Hiroki, Kobayashi Motomasa
Graduate School of Pharmaceutical Sciences, Osaka University, Yamada-oka 1-6, Suita, Osaka, 565-0871, Japan.
National Institute of Biomedical Innovation, 7-6-8 Saitoasagi, Ibaraki, Osaka, 567-0085, Japan.
Chembiochem. 2016 Jan;17(2):181-9. doi: 10.1002/cbic.201500519. Epub 2015 Dec 9.
Hypoxia-adapted cancer cells in tumors contribute to the pathological progression of cancer. Cancer research has therefore focused on the identification of molecules responsible for hypoxia adaptation in cancer cells, as well as the development of new compounds with action against hypoxia-adapted cancer cells. The marine natural product furospinosulin-1 (1) has displayed hypoxia-selective growth inhibition against cultured cancer cells, and has shown in vivo anti-tumor activity, although its precise mode of action and molecular targets remain unclear. In this study, we found that 1 is selectively effective against hypoxic regions of tumors, and that it directly binds to the transcriptional regulators p54(nrb) and LEDGF/p75, which have not been previously identified as mediators of hypoxia adaptation in cancer cells.
肿瘤中适应低氧的癌细胞会促进癌症的病理进展。因此,癌症研究集中于识别癌细胞中负责低氧适应的分子,以及开发对适应低氧的癌细胞有作用的新化合物。海洋天然产物呋喃刺孢菌素-1(1)对培养的癌细胞显示出低氧选择性生长抑制作用,并已显示出体内抗肿瘤活性,尽管其确切作用方式和分子靶点尚不清楚。在本研究中,我们发现1对肿瘤的低氧区域具有选择性作用,并且它直接与转录调节因子p54(nrb)和LEDGF/p75结合,而这两种因子此前尚未被确定为癌细胞低氧适应的介质。